Outcome of small node-negative ER+/HER2+and ER-/HER2+breast cancers might be different

被引：0
|
作者：
Altundag, Kadri [1 ]
机构：
[1] MKA Breast Canc Clin, Ankara, Turkey
来源：
JOURNAL OF BUON | 2020年 / 25卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：583 / 583
页数：1
相关论文
共 50 条
  • [21] EGFR expression in ER negative and HER2 negative breast cancers
    Umemura, SM
    Takekoshi, S
    Osamura, RY
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2004, 52 : S39 - S39
  • [22] Single agent and combined targeting of PI3K, mTOR, HER2 and ER signaling in a panel of HER2+/ER+ versus HER2+/ER- breast cancer cell lines
    O'Brien, N. A.
    Nichols, C. M.
    Thomas, J.
    Conklin, D.
    Kalous, O.
    Linnartz, R.
    Di Tomasso, E.
    Hurvitz, S. A.
    Hirawat, S.
    Slamon, D. J.
    CANCER RESEARCH, 2016, 76
  • [23] Targeting focal adhesion kinase in ER+/HER2+breast cancer improves trastuzumab response
    Lazaro, Glorianne
    Smith, Chris
    Goddard, Lindy
    Jordan, Nicola
    McClelland, Richard
    Barrett-Lee, Peter
    Nicholson, Robert I.
    Hiscox, Stephen
    ENDOCRINE-RELATED CANCER, 2013, 20 (05) : 691 - 704
  • [24] Molecular Classification Predicts Outcome Among Patients With ER+/PR+/HER2-Breast Cancers
    Sandhu, Rupninder
    Parker, Joel
    Anders, Carey
    Coleman, William
    FASEB JOURNAL, 2015, 29
  • [25] The impact of de-escalation of adjuvant systemic therapy on the outcome of women with early ER+/HER2+breast cancer
    Horvat, V. Jeric
    Manevski, D.
    Perme, M. Pohar
    Gazic, B.
    Drev, P.
    Ribnikar, D.
    Matos, E.
    Seruga, B.
    ANNALS OF ONCOLOGY, 2021, 32 : S423 - S423
  • [26] Synthetic lethal strategies in ER/HER2 negative breast cancers
    Tutt, A.
    EJC SUPPLEMENTS, 2010, 8 (03): : 185 - 185
  • [27] How population-based data complement trial data in the adjuvant endocrine treatment of ER+/HER2+breast cancers
    Dackus, G. M. H. E.
    Jozwiak, K.
    Sonke, G. S.
    Van der Wall, E.
    Van Diest, P. J.
    Hauptmann, M.
    Siesling, S.
    Linn, S. C.
    CANCER RESEARCH, 2017, 77
  • [28] Identification of luminal A-like subgroup among ER+/PR+/HER2+breast cancers and its clinical implications
    Zhao, S.
    Jin, X.
    Jiang, Y-Z
    Shao, Z-M
    CANCER RESEARCH, 2019, 79 (04)
  • [29] Implications of HER2 Amplification in Small, Node-Negative Breast Cancers: Do Asians Differ?
    Fuh Yong Wong
    Connie Siew Poh Yip
    Eu Tiong Chua
    World Journal of Surgery, 2012, 36 : 287 - 294
  • [30] Implications of HER2 Amplification in Small, Node-Negative Breast Cancers: Do Asians Differ?
    Wong, Fuh Yong
    Yip, Connie Siew Poh
    Chua, Eu Tiong
    WORLD JOURNAL OF SURGERY, 2012, 36 (02) : 287 - 294
12345